Characteristics | n/N | OR [95% CI] | p-value |
Age range |
|
| 0.2225 |
≤30 | 2/9 | 0.28 [0.04 - 1.18] |
|
]30 - 60] | 26/57 | 2.93 [0.64 - 20.86] |
|
≥60 | 31/58 | 4.01 [0.88 - 28.54] |
|
Sex |
|
| 0.7196 |
Female | 22/40 |
|
|
Male | 39/85 | 0.84 [0.03 - 21.91] |
|
Comorbidities |
|
|
|
HTA | 27/61 | 0.70 [0.34 - 1.41] | 0.3240 |
Diabetes | 26/44 | 1.88 [0.90 - 4] | 0.0935 |
Obesity | 3/8 | 0.70 [0.34 - 1.41] | 0.7182 |
STROKE | 6/12 | 1.05 [0.31 - 3.55] | 0.9315 |
Cardiopathy | 1/7 | 0.16 [0 - 0.98] | 0.0955 |
Fever | 25/47 | 1.32 [0.64 - 2.73] | 0.4503 |
Dyspnea | 36/71 | 1.18 [0.58 - 2.40] | 0.6323 |
Hypotension | 2/5 | 0.59 [0.07 - 3.71] | 0.6675 |
Impaired GC | 35/56 | 1.88 [0.78 - 4.60] | 0.1667 |
SaO2 | 30/44 | 2.14 [1.15 - 4.16] | 0.0014 |
Covid-19 severity |
|
| <0.0001 |
Asymptomatic | 0/3 | - |
|
Mild | 1/7 | 9 [0.21 - 2.52] |
|
Moderate | 13/42 | 3.29 [1.08 - 2.83] |
|
Severe | 28/41 | 4.30 [1.44 - 3.77] |
|
Critical | 12/12 | 9331 [0 - +∞] |
|
eGFR (ml/min/1.73m2) |
|
| 0.0003 |
> 90 | 0/2 | 0.01 [0 - +∞] |
|
]60 - 90] | 5/22 | 0.43 [0.43 - 1.35] |
|
]45 - 60] | 4/16 | 0.49 [0.43 - 1.7] |
|
]30 - 45] | 7/18 | 0.93 [1.03 - 2.92] |
|
]15 - 30] | 12/23 | 1.60 [0.54 - 1.25] |
|
≤15 | 30/42 | 2.50 [1.33 - 5.07] |
|
Hyperglycemia | 16/22 | 4.53 [1.67 - 13.80] | 0.0036 |
Hepatic cytolysis | 49/96 | 0.59 [0.19 - 1.70] | 0.3395 |
Anemia | 33/60 | 1.85 [0.89 - 3.90] | 0.1018 |
Hyperkalemia | 12/17 | 0.38 [0.09 - 1.29] | 0.1107 |
Antibiotics | 55/114 | 0.79 [0.24 - 2.54] | 0.7750 |
Corticosteroids | 25/39 | 2.46 [1.14 - 5.47] | 0.0336 |
Anticoagulant | 47/88 | 1.83 [0.85 - 4.02] | 0.1291 |
Dialysis | 9/17 | 1.20 [0.43 - 3.44] | 0.7973 |
Length of hospitalization < 7 days | 43/55 | 3.58 [1.95 - 7.10] | <0.0001 |